Concepedia

Manjiri Sathe

MS

15

Publications

3.9K

Citations

15

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

CTI BioPharma (Italy)

Manjiri Sathe is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2001–2019

15

Publications

15

IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

David Yen, Jeanne Cheung, Heleen Scheerens et al. · Journal of Clinical Investigation · 2006 · 1.5K citations · Full text

, , +17

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

Jonathan Sherlock, Barbara Joyce-Shaikh, Scott Turner et al. · Nature Medicine · 2012 · 1K citations

, , +13

IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells

Caroline Diveu, Mandy J. McGeachy, Katia Boniface et al. · The Journal of Immunology · 2009 · 331 citations · Full text

Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression

Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai et al. · Journal of Clinical Investigation · 2018 · 214 citations · Full text

, , +20

Tumor Necrosis Factor–dependent Segmental Control of MIG Expression by High Endothelial Venules in Inflamed Lymph Nodes Regulates Monocyte Recruitment

Mary J. Janatpour, S Hudak, Manjiri Sathe et al. · The Journal of Experimental Medicine · 2001 · 173 citations · Full text

, , +20

Rows per page

1–5 of 15